COVID19-OR: Observation, Risk & Recovery [COVID-19]

  • Research type

    Research Study

  • Full title

    COVID19-OR: Observation, Risk & Recovery. An observational study exploring risk assessment and recovery from COVID-19 infection in hospitalised patients.

  • IRAS ID

    280041

  • Contact name

    Luke Hodgson

  • Contact email

    luke.hodgson2@nhs.net

  • Sponsor organisation

    Western Sussex Hospitals NHS Foundation Trust

  • Clinicaltrials.gov Identifier

    N/A, N.A

  • Duration of Study in the UK

    1 years, 0 months, 0 days

  • Research summary

    A novel coronavirus, designated corona virus disease 2019 (COVID-19) has resulted in a Pandemic at the time of writing (27th April) the reported number of confirmed cases exceeding 3 million and over 200000 associated deaths. The burden on global critical care has been considerable. As of 24th Apirl there have been 8752 UK critical care admissions with services under considerable strain, and a mortality rate over 50%. Survivors of critical illness will require significant input. \n\nThis study will perform mixed methods to provide rich data on risk stratification and recovery from critical illness. \n\nRecovery from a novel disease requires documenting and the study will go on to report physical and psychological changes following hospital discharge in survivors. In addition qualitative interviews will be conducted with patients who have survived and been discharged from critical care along with their relatives and treating professionals, to better understand their needs during recovery. [Study relying on COPI notice]

  • REC name

    Yorkshire & The Humber - Bradford Leeds Research Ethics Committee

  • REC reference

    20/YH/0157

  • Date of REC Opinion

    5 May 2020

  • REC opinion

    Further Information Favourable Opinion